ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 181 | |
2 mg | In stock | $ 325 | |
4 mg | In stock | $ 514 | |
10 mg | In stock | $ 874 | |
20 mg | In stock | $ 1345 |
Description | ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis. |
Targets&IC50 | Others: 8.6 μM |
CAS No. | 2041072-41-5 |
Chemical Formula | C23H18N2O4 |
Molecular Weight | 386.407 |
Solubility | DMSO: 85mg/mL (219.98mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom